Remarkable and historic development to clear from the blood clot in just over 3 weeks. Doctors have told Bucks officials this recovery has never been seen before – but occurred due to early treatment, detection, and specialists working on Lillard even before formal diagnosis.
Explore the importance of improved clinical trials to advance cardiovascular research.
Learn more about the impact of inclusivity in clinical research with these expert insights! https://t.co/YPncaBjexY
Our industry has lost a most beloved and legendary leader. MCS founder and CEO, Joe Boyd, passed away peacefully on December 24th. He will be dearly missed by all who had the privilege of knowing him. To honor his life and legacy, read his full obituary: https://t.co/rQU7UMOP9Q.
Welcome to Philadelphia #CardioTwitter, just miles from our King of Prussia headquarters! Visit us at booth 1211 at #AHA23 so we can debate which is the best cheesesteak in the city! @AHAScience
Today we kick off American #HeartMonth. At CSL we are dedicated to innovation and research to combat #heartdisease, the leading cause of death worldwide.
@Simon__Harper Thank you for this. My father raised me and my siblings on The Band with The Last Waltz being a staple viewing for family gatherings. Their music carries on!
Last month, a panel of experts gathered to discuss #Cytomegalovirus in honor of #CMVAwarenessMonth. Learn more about #CMV by viewing the first episode featuring Prof. Stanley Plotkin, @ProfMuldoon, @trishpurcell3, and our VP, Medical Affairs, CMV Vaccines @AllisonAugustMD.
A new paper in @JAHA_AHA by @CMichaelGibson and colleagues evaluates the role of #cholesterol efflux and its potential as a new target for reducing recurrent #cardiovascular events. Read the review paper here: https://t.co/6Gxc0C4cdc
Tissue regeneration has been achieved in certain parts of the body, but not the heart. Ruchira Glaser, our SVP and therapeutic area head of rare disease, autoimmune and cardiovascular sheds light on the potential of #mRNA technology in the cardiology space
https://t.co/WTytNecpNo
Tissue regeneration has been achieved in certain parts of the body, but not the heart. That could change if a novel therapeutic derived from messenger RNA succeeds #CardioTwitter#mRNA https://t.co/5BRWI0JFKh